Pharmaceutical Company Seeks High Court Review In Trademark Dispute

(November 3, 2016, 5:14 PM EDT) -- WASHINGTON, D.C. — A pharmaceutical company in an Oct. 20 petition for writ of certiorari asks the U.S. Supreme Court to answer whether Sections 14(3) and 43(a) of the Lanham Act allow a foreign business that “has neither used nor registered its trademark in the United States to sue the owner of a U.S. trademark for conduct relating to the owner's use of its U.S. mark” (Belmora LLC and Jamie Belcastro v. Bayer Consumer Care AG, et al., No. 16-548, U.S. Sup.).

(Petition for writ of...
To view the full article, register now.